| Literature DB >> 35681580 |
Eni Shehu1, Sigrid Roggendorf1, André Golla2, Antonia Koenig3, Gabriele I Stangl3, Andrea Diestelhorst4, Daniel Medenwald4, Dirk Vordermark4, Anke Steckelberg1, Heike Schmidt1,4.
Abstract
Physical function (PF) in older patients with cancer may decline during and after oncologic therapy. This study aimed to develop and pilot test an individually tailored unsupervised physical activity (PA) program and dietary recommendations to promote PF in older patients with cancer. Following development and pretest, the intervention was pilot tested to explore feasibility, acceptance, adherence and potential benefit. Patients ≥60 years, with heterogeneous cancer diagnoses, starting outpatient radiotherapy were randomized in two study arms: paper-based vs. video-based instructions. Based on assessments of PF, PA, nutrition, cognition, mental health, social support, HRQOL and personal goals, participants received individual recommendations for PA and nutrition. After 12 weeks of intervention (T1), reassessments were performed. The postal 4-week follow-up questionnaire included PA, nutrition and HRQOL. Participants (n = 24, 14 female, mean age 70 ± 7 years) showed comparable characteristics in both study arms. The majority rated the program as helpful. Facilitators and barriers to PA adherence were collected. Both modes of instructions were appreciated equally. PF (EORTC QLQ-C30) declined slightly (not clinically relevant >10 pts.) at group level T0: 76 ± 16, T1: 68 ± 21, T2: 69 ± 24. The intervention was feasible, well accepted, showing potential benefit for the maintenance of PF during outpatient radiotherapy, and should be further tested in a larger sample.Entities:
Keywords: cancer care; health-related quality of life; nutrition; older patients with cancer; physical activity; physical function
Year: 2022 PMID: 35681580 PMCID: PMC9179325 DOI: 10.3390/cancers14112599
Source DB: PubMed Journal: Cancers (Basel) ISSN: 2072-6694 Impact factor: 6.575
Figure 1Exemplary elements of the physical activity program and dietary recommendations.
Demographic and clinical characteristics of all participants (all), video-based group (DI) and paper-based group (PI).
| All ( | DI ( | PI ( | |
|---|---|---|---|
| Age Mean ± SD (Min. Max.) | 70 ± 7 (60–88) | 70 ± 7 (63–88) | 69 ± 7 (60–80) |
| Women | 14 (58) | 6 (46) | 8 (73) |
| Education | |||
| 8 years | 11 | 5 | 6 |
| 10 years | 7 | 6 | 1 |
| 12 years | 6 | 2 | 4 |
| Vocational Training | 11 | 7 | 4 |
| Technical school | 5 | 3 | 2 |
| University | 8 | 3 | 5 |
| Cancer Site ( | |||
| Head and Neck | 8 | 6 | 2 |
| Breast | 7 | 3 | 4 |
| Lung | 5 | 2 | 3 |
| Prostate | 2 | 2 | - |
| Gynecological | 1 | - | 1 |
| Brain | 1 | - | 1 |
| Tumor Classification ( | |||
| T1 | 7 | 4 | 3 |
| T2 | 9 | 5 | 4 |
| T3 | 3 | 2 | 1 |
| T4 | 3 | 1 | 2 |
| N0 | 8 | 4 | 4 |
| N1 | 9 | 5 | 4 |
| N2 | 2 | 1 | 1 |
| N3 | 2 | 1 | 1 |
| M0 | 20 | 10 | 10 |
| M1 | 1 | 1 | - |
| Radiotherapy * | 24 | 13 | 11 |
| Surgery | 15 | 8 | 7 |
| Systemic therapy (e.g., Chemotherapy, endocrine/hormonal) | 18 | 10 | 8 |
| Comorbidities Mean ± SD (Range) | 3 ± 2.4 (0–9) | 3 ± 2.4 (0–8) | 3 ± 3 (0–9) |
| Medications Mean ± SD (Range) | 3 ± 3 (0–9) | 4 ± 3 (0–9) | 3 ± 2 (0–8) |
* The applied RT concepts consisted mainly of normo- or mildly hypofractionated RTs. The maximum single dose was 2.66 Gy for breast cancer and the minimum 1.7 for head and neck cancer. Eleven patients received normofractionated RT.
Objective assessments of physical performance of participants with available data for baseline (T0) and post-assessments (T1) categorized according to reference values.
| Objective Assessments of Physical Performance | T0 | T1 | ||
|---|---|---|---|---|
| Reference | Reference | Reference Met | Reference Not Met | |
| hand grip ( | 19 | 1 | 18 | 2 |
| TUG ( | 19 | 0 | 19 | 0 |
| dual task TUG ( | 10 | 4 | 14 | 0 |
| FTSTS ( | 14 | 5 | 11 | 8 |
| 6 mWT ( | 12 | 1 | 13 | 0 |
| 4-stage balance ( | ||||
| both feet | 20 | 0 | 20 | 0 |
| semi-tandem | 20 | 0 | 20 | 0 |
| tandem | 19 | 1 | 17 | 3 |
| one foot | 18 | 2 | 16 | 4 |
BMI (n = 24) and percentage of the actual in relation to the recommended energy and nutrient intake according to Arends et al. [14] of participants who completed the nutrition assessment (n = 16) (MV ± SD (Min. Max)).
| Item | MV ± SD (Min. Max.) |
|---|---|
| BMI (kg/m2) | 27 ± 2.8 (22.4–33.4) |
| Nutrient intake (% of the recommendation) | |
| Energy | 73 ± 14 (47–105) |
| Protein | 71 ± 15 (41–97) |
| Carbohydrates | 63 ±12 (38–90) |
| Fat | 88 ± 24 (46–142) |
| Fiber | 60 ± 17 (28–88) |
Mean values (MV) and standard deviations (SD) for all functioning scales and symptom scales of the EORTC QLQ-C30 and EORTC ELD-14 over time.
| EORTC QLQ-C30 | T0 ( | T1 ( | T2 ( |
|---|---|---|---|
| Physical Function | 79 ± 16 | 75 ± 20 | 72 ± 24 |
| Role Function | 81 ± 29 | 70 ± 28 | 62 ± 33 * |
| Cognitive Function | 85 ± 19 | 84 ± 17 | 79 ± 23 |
| Emotional Function | 69 ± 17 | 74 ± 20 | 56 ± 27 |
| Social Function | 79 ± 29 | 72 ± 31 | 74 ± 34 |
| Fatigue | 39 ± 25 | 42 ± 29 | 55 ± 27 |
| Pain | 30 ± 32 | 31 ± 37 | 50 ± 33 |
| Nausea | 9 ± 15 | 3 ± 8 | 6 ± 11 |
| Dyspnea | 39 ± 36 | 35 ± 34 | 37 ± 44 |
| Sleeplessness | 37 ± 33 | 43 ± 36 | 63 ± 35 |
| Loss of Appetite | 24 ± 36 | 24 ± 36 | 23 ± 33 |
| Constipation | 21 ± 32 | 16 ± 32 | 19 ± 34 |
| Diarrhea | 17 ± 31 | 8 ± 18 | 9 ± 19 * |
| Financial Problems | 12 ± 22 | 10 ± 19 | 7 ± 18 |
| Global Health Status | 68 ± 19 | 63 ± 20 | 57 ± 23 |
| EORTC ELD-14 | |||
| Mobility | 28 ± 27 | 29 ± 30 | |
| Joint Stiffness | 32 ± 30 | 29 ± 32 | |
| Worries about Others | 58 ± 30 | 48 ± 28 | |
| Future Worries | 60 ± 27 | 49 ± 28 | |
| Illness Burden | 60 ± 25 | 56 ± 30 | |
| Family Support | 71 ± 37 | 64 ± 38 | |
| Maintaining Purpose | 80 ± 20 | 70 ± 26 |
T1 n = 22, * T2 n = 18, T2 n = 17.
Figure 2Individual development of physical function (EORTC QLQ-C30) from baseline (T0) to post-assessments (T1) and follow-up (T2).